ASNS: Actelis Networks, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 2.07
Enterprise Value ($M) 5.94
Book Value ($M) 0.23
Book Value / Share 0.08
Price / Book 9.05
NCAV ($M) -5.08
NCAV / Share -1.68
Price / NCAV -0.41

Profitability (mra)
Return on Invested Capital (ROIC) -1.12
Return on Assets (ROA) -0.52
Return on Equity (ROE) -4.44

Liquidity (mrq)
Quick Ratio 0.49
Current Ratio 0.86

Balance Sheet (mrq) ($M)
Current Assets 5.91
Assets 11.22
Liabilities 10.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 5.61
Operating Income -7.36
Net Income -6.29
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -6.58
Cash from Investing 3.82
Cash from Financing 3.76

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Armistice Capital, Llc 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 4,886 13,860 35.25
2024-04-18 345 3,554 9.71
2024-04-17 7,549 23,346 32.34
2024-04-16 3,503 17,775 19.71
2024-04-15 9,374 42,062 22.29

(click for more detail)

Similar Companies
APTO – Aptose Biosciences Inc. APVO – Aptevo Therapeutics Inc.
ARTL – Artelo Biosciences, Inc. ASRT – Assertio Holdings, Inc.
ATNF – 180 Life Sciences Corp.


Financial data and stock pages provided by
Fintel.io